NCT02194348View on ClinicalTrials.gov

Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

March 31, 2000

Conditions
Healthy
Interventions
DRUG

BIBN 4096 BS - in single rising doses

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02194348 - Study to Determine Tolerability of Single Increasing Dose of BIBN 4096 BS in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter